Influenza H3N2 infection study for pandemic preparedness
Part of Infections, Lungs & breathing clinical trials.
This study gives healthy adults a controlled dose of influenza H3N2 virus to learn how the body responds. The goal is to build a model that can help develop better vaccines and treatments for future flu pandemics.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 45 years old
- You are in good general health, with no chronic medical conditions like diabetes or asthma
- You have a low antibody level to the H3N2 flu strain (measured by a blood test)
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You have not had a flu vaccine in the last 4 months
- You agree to stay in the study unit for about 10 days and return for follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body reacts to a specific flu virus (pH1N1) in a controlled setting. Healthy volunteers are exposed to the virus to help researchers understand the infection and test treatments. You will be monitored closely and given antiviral medication if needed.
This Phase 1 study tests an investigational influenza (flu) approach in a carefully selected group of healthy adults. It may help researchers understand how the flu challenge works and how well the treatment performs and is tolerated.
This study tests how healthy adults respond to being exposed to a flu virus in a controlled setting. You will be closely monitored and may help researchers learn more about flu and potential treatments.
This trial tests new mRNA-based flu vaccines that may provide broader protection against different flu strains. Participants will receive the vaccine and be monitored for safety and their immune response.
This study tests an experimental flu vaccine designed to protect against the H5N8 bird flu virus. It is given with an ingredient that may boost the immune response. The study will check if the vaccine is safe and how well it triggers the body's defenses.
This study tests an experimental flu vaccine (BPL-1357) in healthy volunteers who will later be exposed to H1N1 flu virus in a controlled setting, to see if the vaccine can prevent or reduce illness.
Hear when a new Influenza (Healthy Volunteers) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.